31
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T39924 |
NF-κΒ activator 2
|
NF-κB | NF-κB |
NF-κΒ activator 2 是口服有效的 NF-ҡB 激活剂,EC50为 1.58 μM。它通过增加 NF-κB 的表达和激活来诱导 SOD2。它具有用于研究肌萎缩性侧索硬化症的价值。 | |||
T60507 |
Utreloxastat
EPI 857,PTC857 |
Lipoxygenase | Metabolism |
Utreloxastat (PTC857) 是一种新型 15-脂氧合酶抑制剂,可用于研究肌萎缩侧索硬化症 。 | |||
T13553 |
Arimoclomol
阿瑞洛莫,BRX-220 free base |
HSP | Cytoskeletal Signaling; Metabolism |
Arimoclomol (BRX-220 free base) 是热休克蛋白 (HSP) 的共诱导剂,可用于治疗肌萎缩侧索硬化症的研究。 | |||
T0349 |
Riluzole
PK 26124,RP-54274,利鲁唑 |
GABA Receptor; Sodium Channel; NMDAR | Membrane transporter/Ion channel; Neuroscience |
Riluzole (RP-54274) 是一种谷氨酸拮抗剂,用作抗惊厥药并延长肌萎缩侧索硬化症患者的生存期。它还抑制 GABA 摄取,IC50值为 43 μM。 | |||
T60120 |
SOD1-Derlin-1 inhibitor 56-59
|
Others | Others |
SOD1-Derlin-1 inhibitor 56-59是SOD1-Dderin-1相互作用的抑制剂。SOD1-Derlin-1 inhibitor 56-59在肌萎缩侧索硬化症(ALS)研究中具有潜力。 | |||
T60119 |
SOD1-Derlin-1 inhibitor-1
SOD1-Derlin-1 Inhibitor 56-20 |
Others | Others |
SOD1-Derlin-1 inhibitor-1 (SOD1-Derlin-1 Inhibitor 56-20) (compound 56-20) 是 SOD1-Derlin-1相互作用的抑制剂。SOD1-Derlin-1 inhibitor-1 抑制 SOD1G93A-Derlin-1 复合物,IC50值为 7.11 μM。SOD1-Derlin-1 inhibitor-1 可用于肌萎缩性侧索硬化症的研究。 | |||
T60108 |
PDGFR Tyrosine Kinase Inhibitor III
PDGF Receptor Tyrosine Kinase Inhibitor III |
PDGFR | Angiogenesis; Tyrosine Kinase/Adaptors |
PDGFR Tyrosine Kinase Inhibitor III (PDGF Receptor Tyrosine Kinase Inhibitor III) (PDGF Receptor Tyrosine Kinase Inhibitor III)是一种多激酶抑制剂,可抑制 PDGFR、EGFR、FGFR、PKA 和 PKC 等。PDGFR Tyrosine Kinase Inhibitor III 可用于肌萎缩侧索硬化症的研究。 | |||
T77484 |
Atibuclimab
|
TNF | Apoptosis |
Atibuclimab 是一种靶向 CD14 的嵌合单克隆抗体,由小鼠可变区和人类 IgG4 Fc 区构成。Atibuclimab 可用于治疗肌萎缩侧索硬化症。Atibuclimab 可减少 LPS 诱导的病症,并对 LPS 诱导的促炎细胞因子释放有抑制作用,可延迟抗炎细胞因子可溶性 TNF 受体 I 型的释放, | |||
T14390L |
(2R,3S)-Azelaprag
|
Apelin receptor | GPCR/G Protein |
(2R,3S)-N-(4-(2,6-dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-4H-1,2,4-triazol-3-yl)-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide 是一种Apelin 受体激动剂,对Apelin 受体的EC50为0.012 µM。(2R,3S)-N-(4-(2,6-dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-4H-1,2,4-triazol-3-yl)-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide 可用于治疗心力衰竭、动脉粥样硬化、肥胖、糖尿病、肌萎缩侧索硬化、冠心病、高血压、中风和心肌梗塞等疾病。 | |||
T35689 |
MTP 131 acetate
|
Others | Others |
MTP 131 acetate 是一种小的线粒体靶向四肽。 | |||
T31978 |
GM-608
GM-606,GM-607,GM-604,GM-603,GM-605,GM-602 |
||
GM-604(alirinetide) is a potential treatment for amyotrophic lateral sclerosis and ischemic stroke. | |||
T70892 |
K812
|
||
K812 is an ASK1-specific inhibitor discovered to prolong survival in a mouse model of amyotrophic lateral sclerosis. | |||
T35135 |
WN1316
WN 1316,WN-1316 |
||
WN1316 is a unique neuroprotectant against oxidative injury, being a highly promising remedy for the treatment of amyotrophic lateral sclerosis (ALS). | |||
T11214 |
EPI-589
|
Others | Others |
EPI-589, a quinone derivative and oxidoreductase enzyme inhibitor, is considered safe and well tolerated, showing promise for the treatment of amyotrophic lateral sclerosis (ALS). | |||
T82704 |
CMB-087229
|
||
CMB-087229为一种针对突变SOD1蛋白的聚集阻断剂,具有IC50值为67 nM,主要用于肌萎缩侧索硬化症的研究。 | |||
T81372 |
Proteasome-activating peptide 1
|
||
Proteasome-activating peptide 1 是一种肽,其作用是提升胰凝乳蛋白酶样蛋白酶体(proteasome)的催化活性,有效增强体外及细胞培养环境下的蛋白质降解效率。此外,该肽能阻止肌萎缩侧索硬化症(Amyotrophic Lateral Sclerosis, ALS)细胞模型中蛋白质的过度聚集。 | |||
T81580 |
Ozanezumab
GSK1223249 |
||
Ozanezumab (GSK1223249) 是一种anti-Nogo-A 单克隆抗体,用于肌萎缩侧索硬化症 (ALS) 及多发性硬化症研究。 | |||
T70893 | K811 | ||
K811 is an ASK1-specific inhibitor that prolongs survival in a mouse model of amyotrophic lateral sclerosis. K811 efficiently prevented cell proliferation in cell lines with high ASK1 expression and in HER2-overexpressing GC cells. Treatment with K811 reduced sizes of xenograft tumors by downregulating proliferation markers. | |||
T39498 |
Tofersen
BIIB067,ISIS-SOD1Rx |
||
Tofersen (BIIB067) is an antisense oligonucleotide utilized to inhibit the synthesis of superoxide dismutase 1 (SOD1) protein by facilitating the degradation of SOD1 mRNA via the RNase H-dependent mechanism. This compound holds potential for amyotrophic lateral sclerosis (ALS) research. | |||
T72959 |
NUCC-0000323
|
||
NUCC-0000323 是一种针对超氧化物歧化酶 1 (SOD1) 的有效抑制剂,能够抑制 SOD1 的表达。该化合物在肌萎缩侧索硬化症 (ALS) 研究中有潜在应用。 | |||
T61128 |
c-ABL-IN-2
|
||
C-ABL-IN-2 is a highly effective inhibitor of the c-Abl protein, which plays a significant role in the development of several diseases, including cancer. This compound exhibits promise for investigating neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD), as well as cancer. (Source: WO2020260871A1, compound 25) [1]. | |||
T61546 |
c-ABL-IN-3
|
||
c-ABL-IN-3, a highly effective c-Abl inhibitor, exhibits promising potential for studying neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD), as well as cancer [1]. The activation of c-Abl has been strongly implicated in a range of diseases, notably cancer [1]. It offers valuable opportunities for research in these fields [1]. | |||
T73117 |
ROCK2-IN-5
|
||
ROCK2-IN-5是一种复合型化合物,融合了Rho激酶抑制剂fasudil以及NRF2诱导剂咖啡酸和阿魏酸的结构元素。该化合物展示了优秀的多靶点作用特性和较高的耐受性。ROCK2-IN-5在针对SOD1基因变异型ALS研究中具备应用潜力。 | |||
T82560 |
di-Ellipticine-RIBOTAC
|
PROTACs | PROTAC |
Di-Ellipticine-RIBOTAC是一款双功能小分子,在体外和体内肌萎缩侧索硬化(ALS)模型中能够减少c9ALS/FTD r(G4C2)的重复扩增。 | |||
T60966 |
UCPH-102
|
||
UCPH-102 可用于研究阿尔茨海默病、肌萎缩性侧索硬化症、慢性疼痛和强迫症等,具有良好的血脑通透性。UCPH-102 是高度选择性的 EAAT1抑制剂,IC50值为0.43 μM。UCPH-102 还对 T-ALL 细胞表现出特异性的抗增殖作用。 | |||
T78603 |
Sotuletinib dihydrochloride
BLZ945 dihydrochloride |
c-Fms | Tyrosine Kinase/Adaptors |
Sotuletinib (BLZ945) dihydrochloride 是一种CSF1-R特异性抑制剂,具有口服活性和血脑屏障透过性 (IC50=1 nM)。它能诱导肿瘤细胞凋亡,并在小鼠模型中有效抑制肿瘤生长,适用于癌症和肌萎缩侧索硬化症 (ALS) 研究。 | |||
T37608 |
Riluzole-13C,15N2
Riluzole-13C,15N2 |
||
Riluzole-13C,15N2 is intended for use as an internal standard for the quantification of riluzole by GC- or LC-MS. Riluzole is a benzothiazole derivative with anti-excitotoxic effects that acts by blocking the presynaptic release of glutamate, indirectly antagonizing glutamate receptors, and inactivating neuronal voltage-gated Na+ channels (ED50 = 2.3 μM). Riluzole suppresses glutamate-induced seizures in rats at an ED50 value of 3.2 mg/kg and displays neuroprotective effects in hypoxic animals a... | |||
T76243 |
Proteasome-activating peptide 1 TFA
|
||
Proteasome-activating peptide 1 TFA 是一种肽类蛋白酶体激活剂,能显著增强胰凝乳蛋白酶样蛋白酶体的催化活性,进而提升体外及培养环境中的蛋白质水解效率。此外,Proteasome-activating peptide 1 TFA 还能有效阻止肌萎缩侧索硬化症细胞模型内的蛋白质聚集现象。 | |||
T60953 | BSc5367 | ||
BSc5367 是Nek1激酶结构域的有效抑制剂,IC50值为 11.5 nM。Nek1 是一种NIMA 相关的蛋白激酶,在细胞周期调节、DNA 修复和微管调节中起着关键作用。Nek1 功能障碍在肌萎缩侧索硬化症 (ALS)、多囊肾病 (PKD) 和几种类型的放疗耐药性癌症中发挥关键作用。BSc5367 为更好的理解上述疾病提供了有用工具。 | |||
T36499 |
CuATSM
|
||
The metallo-protein Cu/Zn-superoxide dismutase (SOD1) is a ubiquitous enzyme responsible for scavenging superoxide radicals. Mutations in SOD1, which alter its metal binding capacity and can result in protein misfolding and aggregation, have been linked to familial amyotrophic lateral sclerosis (ALS). Cu-ATSM is an orally bioavailable, blood-brain barrier permeable complex that has traditionally been used in cellular imaging experiments to selectively label hypoxic tissue via its susceptibility ... | |||
T38218 |
1-Stearoyl-2-docosahexaenoyl-sn-glycero-3-PC
|
||
1-Stearoyl-2-docosahexaenoyl-sn-glycero-3-PC 是一种在生物膜中的磷脂,在 sn-1 和 sn-2 位置分别含有硬脂酸和二十二碳六烯酸。它已被用于研究脂膜的组织和动力学。在超氧化物歧化酶 1 突变体转基因小鼠肌萎缩性脊髓侧索硬化症(ALS)模型中1-Stearoyl-2-docosahexaenoyl-sn-glycero-3-PC 的水平在疾病晚期会在 L5 前角下降。1-Stearoyl-2-docosahexaenoyl-sn-glycero-3-PC 可用于研究生物膜。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T22911 |
β-N-methylamino-L-alanine hydrochloride
L-BMAA hydrochloride |
Others | Others |
β-N-methylamino-L-alanine hydrochloride (L-BMAA hydrochloride) 是由蓝细菌产生的一种神经毒素,既有导致肌萎缩性侧索硬化症 (ALS) 以及其他可能的神经退行性疾病可能性。 | |||
T2532 |
Tauroursodeoxycholate
Taurolite,牛磺熊去氧胆酸,Tauroursodeoxycholic Acid,UR 906,Ursodeoxycholyltaurine,TUDCA |
Apoptosis; ERK; P450; Caspase; Endogenous Metabolite | Apoptosis; MAPK; Metabolism; Proteases/Proteasome |
Tauroursodeoxycholate (UR 906),又称 ursodoxicoltaurine,是一种高度亲水性的三级胆汁酸,在人体内以低浓度产生。Tauroursodeoxycholate 是 ursodeoxycholic acid 更亲水的形式,而 ursodeoxycholic acid 是人类体内自然产生的更丰富的胆汁酸。Tauroursodeoxycholate 正在研究用于几种疾病,如原发性胆汁性肝硬化(PBC)、胰岛素抵抗、淀粉样变性、囊性纤维化、胆汁淤滞和肌萎缩性侧索硬化症。 | |||
T75527 |
Chrexanthomycin C
|
||
Chrexanthomycin C 是一种具有显著生物活性的海洋天然产物,具有口服活性。Chrexanthomycin C 对 DNA (G4C2)4 G4 具有结合亲和力,Kd 值为 2.8 mM。Chrexanthomycin C 可用于肌萎缩侧索硬化症 (ALS) 等神经退行性疾病的研究。 |